These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 8564951)
1. Detection of 1, N2-propanodeoxyguanosine adducts as potential endogenous DNA lesions in rodent and human tissues. Nath RG; Ocando JE; Chung FL Cancer Res; 1996 Feb; 56(3):452-6. PubMed ID: 8564951 [TBL] [Abstract][Full Text] [Related]
2. 1,N2-propanodeoxyguanosine adducts: potential new biomarkers of smoking-induced DNA damage in human oral tissue. Nath RG; Ocando JE; Guttenplan JB; Chung FL Cancer Res; 1998 Feb; 58(4):581-4. PubMed ID: 9485001 [TBL] [Abstract][Full Text] [Related]
3. Simultaneous quantification of 1,N2-propano-2'-deoxyguanosine adducts derived from acrolein and crotonaldehyde in human placenta and leukocytes by isotope dilution nanoflow LC nanospray ionization tandem mass spectrometry. Chen HJ; Lin WP Anal Chem; 2009 Dec; 81(23):9812-8. PubMed ID: 19899782 [TBL] [Abstract][Full Text] [Related]
4. Detection of exocyclic 1,N2-propanodeoxyguanosine adducts as common DNA lesions in rodents and humans. Nath RG; Chung FL Proc Natl Acad Sci U S A; 1994 Aug; 91(16):7491-5. PubMed ID: 8052609 [TBL] [Abstract][Full Text] [Related]
5. A solid-phase extraction/high-performance liquid chromatography-based (32)P-postlabeling method for detection of cyclic 1,N(2)-propanodeoxyguanosine adducts derived from enals. Pan J; Davis W; Trushin N; Amin S; Nath RG; Salem N; Chung FL Anal Biochem; 2006 Jan; 348(1):15-23. PubMed ID: 16289438 [TBL] [Abstract][Full Text] [Related]
6. Role of 1,N2-propanodeoxyguanosine adducts as endogenous DNA lesions in rodents and humans. Chung FL; Zhang L; Ocando JE; Nath RG IARC Sci Publ; 1999; (150):45-54. PubMed ID: 10626207 [TBL] [Abstract][Full Text] [Related]
7. Effect of glutathione depletion on exocyclic adduct levels in the liver DNA of F344 rats. Nath RG; Ocando JE; Richie JP; Chung FL Chem Res Toxicol; 1997 Nov; 10(11):1250-3. PubMed ID: 9403178 [TBL] [Abstract][Full Text] [Related]
8. Detection of cyclic 1,N2-propanodeoxyguanosine adducts in DNA of rats treated with N-nitrosopyrrolidine and mice treated with crotonaldehyde. Chung FL; Young R; Hecht SS Carcinogenesis; 1989 Jul; 10(7):1291-7. PubMed ID: 2736720 [TBL] [Abstract][Full Text] [Related]
9. Cancer risk assessment for crotonaldehyde and 2-hexenal: an approach. Eder E; Schuler D; Budiawan IARC Sci Publ; 1999; (150):219-32. PubMed ID: 10626223 [TBL] [Abstract][Full Text] [Related]
10. A 32P-postlabeling method for simultaneous detection and quantification of exocyclic etheno and propano adducts in DNA. Nath RG; Chen HJ; Nishikawa A; Young-Sciame R; Chung FL Carcinogenesis; 1994 May; 15(5):979-84. PubMed ID: 8200104 [TBL] [Abstract][Full Text] [Related]
11. 32P-postlabelling with high-performance liquid chromatography for analysis of abundant DNA adducts in human tissues. Yang K; Fang JL; Li D; Chung FL; Hemminki K IARC Sci Publ; 1999; (150):205-17. PubMed ID: 10626222 [TBL] [Abstract][Full Text] [Related]
12. Development of a 32P-postlabeling method for the detection of 1, N2-propanodeoxyguanosine adducts of 2-hexenal in vivo. Schuler D; Budiawan B; Eder E Chem Res Toxicol; 1999 Apr; 12(4):335-40. PubMed ID: 10207122 [TBL] [Abstract][Full Text] [Related]
13. An improved 32P-postlabeling/high-performance liquid chromatography method for the analysis of the malondialdehye-derived 1, N2-propanodeoxyguanosine DNA adduct in animal and human tissues. Yi P; Sun X; Doerge DR; Fu PP Chem Res Toxicol; 1998 Sep; 11(9):1032-41. PubMed ID: 9760277 [TBL] [Abstract][Full Text] [Related]
14. Glutathione depletion enhances the formation of endogenous cyclic DNA adducts derived from t-4-hydroxy-2-nonenal in rat liver. Chung FL; Komninou D; Zhang L; Nath R; Pan J; Amin S; Richie J Chem Res Toxicol; 2005 Jan; 18(1):24-7. PubMed ID: 15651845 [TBL] [Abstract][Full Text] [Related]
15. Cancer risk assessment for the environmental mutagen and carcinogen crotonaldehyde on the basis of TD(50) and comparison with 1,N(2)-propanodeoxyguanosine adduct levels. Eder E; Budiawan Cancer Epidemiol Biomarkers Prev; 2001 Aug; 10(8):883-8. PubMed ID: 11489755 [TBL] [Abstract][Full Text] [Related]
16. Development of a 32P-postlabelling method for the detection of 1,N2-propanodeoxyguanosine adducts of crotonaldehyde in vivo. Schuler BD; Eder E Arch Toxicol; 2000 Sep; 74(7):404-14. PubMed ID: 11043496 [TBL] [Abstract][Full Text] [Related]
17. Lipid peroxidation-induced putative malondialdehyde-DNA adducts in human breast tissues. Wang M; Dhingra K; Hittelman WN; Liehr JG; de Andrade M; Li D Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):705-10. PubMed ID: 8877062 [TBL] [Abstract][Full Text] [Related]
18. 32P-postlabelling methods for cyclic DNA adducts. Watson WP; Crane AE; Steiner S IARC Sci Publ; 1993; (124):255-62. PubMed ID: 8225493 [TBL] [Abstract][Full Text] [Related]
19. Formation of cyclic 1,N2-propanodeoxyguanosine adducts in DNA upon reaction with acrolein or crotonaldehyde. Chung FL; Young R; Hecht SS Cancer Res; 1984 Mar; 44(3):990-5. PubMed ID: 6318992 [TBL] [Abstract][Full Text] [Related]
20. (E)-2-hexenal-induced DNA damage and formation of cyclic 1,N2-(1,3-propano)-2'-deoxyguanosine adducts in mammalian cells. Gölzer P; Janzowski C; Pool-Zobel BL; Eisenbrand G Chem Res Toxicol; 1996; 9(7):1207-13. PubMed ID: 8902278 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]